Please Enter a Search Term
 
"Building a Healthy Tomorrow"  TM
AdmissionsCommunicationsDivision/DisciplineEducationFaculty/StaffLeadershipResearchStudents


Dawn Armstrong

Oncology
M.D., Memorial, FRCPC

Clinical Assistant Professor of Oncology (Medical Oncology)

Dr. H. Bliss Murphy Cancer Centre
2054, Cancer Clinic
300 Prince Philip Drive,
St. John’s, NL A1B 3V6
t: 709-777-7802
f: 709-777-8756
lab:

Bio-SketchDr. Dawn Armstrong, MD FRCPC,  is a Medical Oncologist with the Cancer Care Program in St. John’s, Newfoundland and a Clinical Associate Professor within the Discipline of Oncology at the Faculty of Medicine, Memorial University of Newfoundland.  She received her MD from Memorial University in 2009, and completed a residency in Internal Medicine at Memorial University in 2012.  She then went on to complete her Medical Oncology training at the University of Alberta in 2014. 
Dr. Armstrong is involved in the treatment of patients with Gastrointestinal, Neurological, Cutaneous, Breast and Unknown Primary Malignancies. She is also an investigator in a number of clinical trials, and has a keen interest in teaching Medical Students and Resident Trainees.

PEER REVIEWED PUBLICATIONS:

Armstrong, D., Raissouni, S., Hiller, J. P., Mercer, J., Powell, E., MacLean, A., ... & Zhou, K. (2015). Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study. Clinical colorectal cancer, 14(4), 291-295.
 
Kim, C. A., Spratlin, J. L., Armstrong, D. E., Ghosh, S., & Mulder, K. E. (2014). Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience. Clinical colorectal cancer, 13(3), 199-206.
 
Armstrong, D. E., Spratlin, J. L., Kim, C., & Mulder, K. E. (2014, May). Adjuvant chemotherapy (AC) in elderly patients with stage II colon cancer: A single institute experience. In ASCO Annual Meeting Proceedings (Vol. 32, No. 15_suppl, p. e20526).
 
Raissouni, S., Armstrong, D. E., Price Hiller, J. A., Mercer, J., Powell, E. D., MacLean, A., ... & Zhou, K. (2014, January). Predictors of treatment interruption/dose reduction of neoadjuvant chemotherapy for rectal cancer: A multicenter study. In ASCO Annual Meeting Proceedings (Vol. 32, No. 3_suppl, p. 580).
 
Armstrong, D. E., Ali, H., Powell, E. D., Price Hiller, J. A., Tang, P., Bebb, D. G., ... & Easaw, J. C. (2012, May). Predictors of pathologic complete response (pCR) after neoadjuvant chemoradiation (Neo CRT) for rectal cancer: A multicenter population-based study. In ASCO Annual Meeting Proceedings (Vol. 30, No. 15_suppl, p. e14073).
 
Armstrong D, Powell E, Seal M, Rorke S, Laing K et al. (2011) Nasopharyngeal cancer in Newfoundland and Labrador: our 7 year experience 2002-2009. Oncology Exchange 10(2): e4-7
 
Jones, M. W., O'Reilly, P. T., McPherson, A. A., McParland, T. L., Armstrong, D. E., Cox, A. J., ... & Bentzen, P. (2003). Development, characterisation, inheritance, and cross-species utility of American lobster (Homarus americanus) microsatellite and mtDNA PCR-RFLP markers. Genome, 46(1), 59-69.












 


 
Copyright © 2017 Memorial University of Newfoundland.   Newfoundland and Labrador, Canada.